Compound 715
Identifiers
- Canonical SMILES:
CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CC[C@@H]2[C@H]1[C@H](CN2C(=O)OCc1ccccc1)c1c[nH]c2cc(F)ccc12
- IUPAC name:
benzyl (3aR,6S,6aR)-1-[(2S)-2-cyclohexyl-2-[[(2S)-2-(methylamino)propanoyl]amino]acetyl]-6-(6-fluoro-1H-indol-3-yl)-2,3,3a,5,6,6a-hexahydropyrrolo[3,2-b]pyrrole-4-carboxylate
- InChi:
InChI=1S/C34H42FN5O4/c1-21(36-2)32(41)38-30(23-11-7-4-8-12-23)33(42)39-16-15-29-31(39)27(26-18-37-28-17-24(35)13-14-25(26)28)19-40(29)34(43)44-20-22-9-5-3-6-10-22/h3,5-6,9-10,13-14,17-18,21,23,27,29-31,36-37H,4,7-8,11-12,15-16,19-20H2,1-2H3,(H,38,41)/t21-,27+,29+,30-,31+/m0/s1
- InChiKey:
ZTOGCFIFXCXPFV-USSLBTQDSA-N
External links
![]() 45139135 |
External search
|
|
|
|
|
Bibliography (1)
| Publication | Name |
|---|---|
| Stephen M. Condon, Matthew G. Laporte, Tetralogic Pharmaceuticals Corp.. . Iap inhibitors None. | 99 |
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| XIAP / Smac | 7.00 | cancer | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 603.32 g/mol | |||
| HBA | 9 | |||
| HBD | 3 | |||
| HBA + HBD | 12 | |||
| AlogP | 4.06 | |||
| TPSA | 106.77 | |||
| RB | 9 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 |
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
|---|---|---|---|---|---|---|---|---|
| WO2010033531 | 99 | XIAP P98170 |
|
Biochemical assay | Fluorescence Polarization | pKd (dissociation constant, -log10) | 7.00 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.7052 | Metergoline | DB13520 | |
| 0.6629 | Anamorelin | DB06645 | |
| 0.6554 | [1-(3-hydroxy-2-oxo-1-phenethyl-propylcarbamoyl)2-phenyl-ethyl]-carbamic acid pyridin-4-ylmethyl ester | DB02128 | |
| 0.6546 | LTX-315 | DB12748 | |
| 0.6512 | Omiganan | DB06610 | |
| 0.6400 | Murepavadin | DB14777 | |
| 0.6347 | Gramicidin D | DB00027 | |
| 0.6321 | Pentagastrin | DB00183 | |
| 0.6286 | BQ-123 | DB12054 | |
| 0.6286 | Somatoprim | DB12777 | |
| 0.6256 | Dihydroergotamine | DB00320 | |
| 0.6199 | Dihydroergocristine | DB13345 | |
| 0.6193 | 5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID | DB08493 | |
| 0.6143 | Nepadutant | DB12538 | |
| 0.6119 | Dihydroergocornine | DB11273 |




